Karoo Health, a technology company focused on cardiovascular care, has announced the successful closing of a $16.2 million Series A financing round. The investment was co-led by prominent digital health investors 7wire Ventures and Allumia Ventures, with participation from firms including First Trust Capital Partners. This new capital will fuel the advancement of its AI-native platform and expand its growing network of health plan and cardiology practice partnerships.
Addressing a Fragmented System
Cardiovascular disease remains the leading cause of death and the largest driver of healthcare costs in the United States. A primary challenge is that care delivery is highly fragmented, with critical patient data scattered across disparate clinical systems, claims records, and pharmacies. This systemic disconnect contributes to delayed diagnoses, inconsistent management of chronic conditions, and a high rate of avoidable hospitalizations and procedures.
A Unified Platform for Cardiac Care
To combat this fragmentation, Karoo Health is building a comprehensive operating system designed specifically for cardiovascular care. Its platform unifies disparate data sources to create a single, coherent view of each patient's journey. This integrated system empowers care teams with the tools for earlier risk detection, improved care coordination, and data-driven delivery of treatment.
Investor Confidence and Strategic Vision
The investment signifies strong confidence from seasoned healthcare venture capitalists, with Lee Shapiro of 7wire Ventures and Jeff Stolte of Allumia Ventures joining Karoo's Board of Directors. Shapiro highlighted that Karoo is creating the "connective layer" needed to solve the system's fragmentation and allow teams to act on a complete patient picture. Stolte expressed his belief that Karoo possesses the technology and vision to fundamentally change how cardiac care is delivered.
Proven Impact and Future Growth
Karoo's platform is already demonstrating significant real-world impact across its network of more than 600 cardiology providers in 11 states. Independent analyses of its programs with leading health plans have reported remarkable outcomes, including reductions of over 40% in both emergency department visits and inpatient admissions. Furthermore, early results show a greater than 10% reduction in the total cost of care for its managed populations.
With the new capital, Karoo Health plans to accelerate the development of its AI-native cardiovascular platform. Key initiatives include refining its predictive models for risk stratification and enhancing its clinical signal detection and care coordination infrastructure. The company will also strategically expand its engineering and clinical teams to support the scaling of deployments with its payer and provider partners.
This Series A financing represents a significant milestone for Karoo Health and its mission to free people from the burden of cardiovascular disease. According to CEO Ian Koons, the capital will enable a major step toward ensuring every American can access more coordinated and effective care. By building a more connected and proactive model, the company is poised to make a lasting impact on patient outcomes and healthcare costs.